跳至主要内容
临床试验/TCTR20180328002
TCTR20180328002进行中(未招募)3 期

The efficacy of different warfarin initiating doses (3 mg versus 5 mg) and the corresponding dosing schedule in patients diagnosed with venous thromboembolism

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 56 人开始时间: 2018年3月28日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • Adult patients aged 18 years or older who were diagnosed with symptomatic proximal deep vein thrombosis (DVT) of the extremity or DVT at other unusual sites (for example, cerebral venous sinus thrombosis, and/or pulmonary embolism (PE)) and planned to receive warfarin with a target INR of 2.0â€3.0.

排除标准

  • An absolute contraindication to anticoagulant therapy (e.g., active bleeding), high risk of bleeding (e.g., recent eye, brain or spinal cord surgery within 3 months), history of concurrent congestive heart failure, history of liver cirrhosis (Child Pugh class B or C), concomitant use of aspirin, prolonged baseline PT and/or activated partial thromboplastin time (aPTT) above the upper normal limits, platelet counts of less than 50×109/L, serum albumin less than 2.0 g/dL, pregnancy, and patients who were unable to perform oral feeding

研究者

发起方
Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验